Special-purpose acquisition company

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation – ICU

Retrieved on: 
Monday, April 8, 2024
SeaStar, Classification, News, LLP, Judgement, Special-purpose acquisition company, Pomerantz

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of SeaStar Medical Holding Corporation (“SeaStar” or the “Company”) (NASDAQ: ICU).

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of SeaStar Medical Holding Corporation (“SeaStar” or the “Company”) (NASDAQ: ICU).
  • The investigation concerns whether SeaStar and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

SeaStar Medical to Restate Financials, Sets Business Update Call for April 17

Retrieved on: 
Wednesday, March 27, 2024
PIN, Sepsis, AKI, SeaStar, Classification, Security (finance), Judgement, Bank statement, Acute kidney injury, Special-purpose acquisition company, Annual report

DENVER, March 27, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that it will restate its financial statements for the fiscal year ended December 31, 2022 and for the interim periods ended March 31, 2023, June 30, 2023 and September 30, 2023.

Key Points: 
  • The restatement will impact the accounting treatment and classification of certain outstanding warrants and the prepaid forward purchase arrangement that was terminated in June 2023.
  • “The restatement is not expected to have a material impact on our business operations or our cash position, but rather is related to the reporting of non-cash accounting items,” said Eric Schlorff, Chief Executive Officer of SeaStar Medical.
  • “We look forward to providing a more detailed update on our progress and outlook during our business update conference call.”
    SeaStar Medical’s management will hold a business update conference call on Wednesday, April 17 at 4:00 p.m. Eastern time (1:00 p.m. Pacific time).
  • Stockholders and other interested parties may also participate in the conference call by dialing 866-777-2509 from within the U.S. or 412-317-5413 from outside the U.S., and requesting the SeaStar Medical call.

R&S Group acknowledges VERAISON’s decision to gradually return capital to its shareholders

Retrieved on: 
Wednesday, March 13, 2024
Special-purpose acquisition company, News, SIX Swiss Exchange, Sale

Sissach/BL, Switzerland, 8 March 2024 – R&S Group Holding AG (SIX: RSGN) took note of the news release by VERAISON Capital AG (“VERAISON”) published on 7 March 2024 wherein the asset manager informs about its decision to gradually return capital to its shareholders.

Key Points: 
  • Sissach/BL, Switzerland, 8 March 2024 – R&S Group Holding AG (SIX: RSGN) took note of the news release by VERAISON Capital AG (“VERAISON”) published on 7 March 2024 wherein the asset manager informs about its decision to gradually return capital to its shareholders.
  • VERAISON, through its SICAV Engagement Fund, acted as sponsor of the Special Purpose Acquisition Company (“SPAC”) VT5 Acquisition Company AG (“VT5”) which successfully concluded the Initial Business Combination (De-SPAC) with R&S Group at the end of last year.
  • This resulted in the listing of RSGN at SIX Swiss Exchange on 13 December 2023.
  • R&S Group acknowledges VERAISON’s decision to gradually return capital to its shareholders and is prepared to support VERAISON in the sale of their RSGN shares whereby the lock-up commitment shall be maintained.

SEI Appoints Sean Denham as CFO

Retrieved on: 
Monday, February 5, 2024
File, CFO, Risk management, Audit, PACT, Certified Public Accountant, Capital, McGonagle, Workforce, Ernst & Young, Employment, United Way, Commerce, Lehigh University, Special-purpose acquisition company, Grant Thornton International, Atlantic Coast, Culture, Delaware Valley, Accounting, Management

OAKS, Pa., Feb. 5, 2024 /PRNewswire/ -- SEI ® (NASDAQ:SEIC) today announced the appointment of Sean Denham as an Executive Vice President and Chief Financial Officer, reporting to CEO Ryan Hicke.

Key Points: 
  • OAKS, Pa., Feb. 5, 2024 /PRNewswire/ -- SEI ® (NASDAQ:SEIC) today announced the appointment of Sean Denham as an Executive Vice President and Chief Financial Officer, reporting to CEO Ryan Hicke.
  • Denham's employment will begin on March 18, 2024, and his appointment as CFO will be effective on the day following the resignation of current CFO Dennis McGonigle, whose departure plans were announced by SEI in July 2023.
  • Denham succeeds McGonigle, who has served in a number of different roles and leadership positions at SEI for nearly 40 years.
  • Sean leads by example and embodies the values that our stakeholders expect from us to the same degree as Dennis.

MarcumAsia Expands with New Hong Kong Office

Retrieved on: 
Thursday, February 1, 2024
Professional Services, Finance, Consulting, Asset Management, Banking, Accounting, International Commerce Centre, Public, Partner (business rank), Zeekr, IPO, PCAOB, Gold, City, Special-purpose acquisition company, Tutoring

Marcum Asia CPAs LLP (MarcumAsia) announced the opening of its newest Asia-based office in Hong Kong.

Key Points: 
  • Marcum Asia CPAs LLP (MarcumAsia) announced the opening of its newest Asia-based office in Hong Kong.
  • “The Hong Kong office is a natural extension of the firm as more clients across mainland China and Southeast Asia navigate their growth path, including U.S. listing goals.”
    The Hong Kong office, with a capacity for 50 people, is located in the International Commerce Centre in Kowloon, Hong Kong.
  • Additionally, the firm offers non-audit consulting services for SPAC managers and operating companies listed on the Singapore or Hong Kong Stock Exchanges.
  • “We will extend these standards to our new Hong Kong staff with oversight by our diligent regional partners,” Pinchuk concluded.

FTI Consulting Survey Identifies Top Risks and Opportunities for Healthcare & Life Sciences Sector in 2024

Retrieved on: 
Wednesday, December 13, 2023
Policy, Special-purpose acquisition company, Food, FTI Consulting, Health care, Drug development, Government, IRA, Communes of Burundi, Research, Inflation, Vaccine, FCN, Legislation, AI, Artificial intelligence, Food and Drug Administration, Senior, Pharmaceutical industry

WASHINGTON, Dec. 13, 2023 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the results of its U.S. Healthcare & Life Sciences Industry Outlook 2024, which found that although leaders in the sector are less optimistic about the industry’s financial outlook for 2024, they expect technologies such as artificial intelligence (“AI”) to transform drug development and revolutionize the healthcare and life sciences industry.

Key Points: 
  • Among the top findings, sector leaders are notably less optimistic about the industry in 2024 compared to previous years, with 68% of respondents feeling optimistic about the healthcare and life sciences industry overall, down 8% compared to 76% from last year’s survey .
  • Cybersecurity made the largest jump, climbing from the seventh most-significant risk in last year’s survey.
  • Half of the companies surveyed plan to increase their overall budget from 2023, with 48% investing more in research and development (“R&D”).
  • “Companies can build momentum toward smarter, more effective policies by strengthening alliances and communicating effectively to multiple stakeholders ahead of policy initiatives.”

flyExclusive and EG Acquisition Corporation Announce Closing of Business Combination

Retrieved on: 
Wednesday, December 27, 2023
Transport, Air, Special-purpose acquisition company, Economics, LLP, Vinson & Elkins, Acceleration, Management

flyExclusive, a leading provider of premium private jet charter experiences, and EG Acquisition Corp. (NYSE: EGGF), a Special Purpose Acquisition Company (SPAC) sponsored by EnTrust Global and GMF Capital, today announced the completion of their previously announced business combination.

Key Points: 
  • flyExclusive, a leading provider of premium private jet charter experiences, and EG Acquisition Corp. (NYSE: EGGF), a Special Purpose Acquisition Company (SPAC) sponsored by EnTrust Global and GMF Capital, today announced the completion of their previously announced business combination.
  • The business combination was approved at a special meeting of EG Acquisition Corp.’s stockholders on December 18, 2023.
  • “Today marks another milestone in our company’s mission to elevate the private aviation experience,” said Jim Segrave, Chief Executive Officer and founder of flyExclusive.
  • In connection with the closing of the business combination, the Company has canceled the annual meeting, which was previously scheduled to be held on December 27, 2023 at 5:00 p.m. Eastern Time.

EG Acquisition Corp. Announces Update on Business Combination and Annual Meeting

Retrieved on: 
Thursday, December 21, 2023
Professional Services, Finance, Special-purpose acquisition company, Business analyst, Person, Date, Special, Trust, Annual general meeting, Name, Extension, Annual, Communication, Security (finance)

Following and subject to the consummation of the Business Combination, flyExclusive’s Class A common stock and public warrants would trade on the NYSE American under the symbols “FLYX” and “FLYXW,” respectively.

Key Points: 
  • Following and subject to the consummation of the Business Combination, flyExclusive’s Class A common stock and public warrants would trade on the NYSE American under the symbols “FLYX” and “FLYXW,” respectively.
  • The record date for determining the Company stockholders entitled to receive notice of and to vote at the Annual Meeting remains the close of business on December 4, 2023 (the “Record Date”).
  • Stockholders who do not wish to withdraw their previously submitted redemption requests (either in connection with the Special Meeting or the upcoming Annual Meeting) need not take any further action.
  • This communication does not contain all the information that should be considered concerning the Annual Meeting.

EG Acquisition Corp. Announces Update on Business Combination and Annual Meeting

Retrieved on: 
Tuesday, December 19, 2023
Professional Services, Finance, Transfer, Special-purpose acquisition company, Business analyst, Person, Date, Special, Trust, Annual general meeting, Name, Extension, Annual, Communication

Approximately 97% of the shares that voted on the Business Combination voted in favor of it, representing approximately 90% of the outstanding shares of EG’s common stock.

Key Points: 
  • Approximately 97% of the shares that voted on the Business Combination voted in favor of it, representing approximately 90% of the outstanding shares of EG’s common stock.
  • The record date for determining the Company stockholders entitled to receive notice of and to vote at the Annual Meeting remains the close of business on December 4, 2023 (the “Record Date”).
  • Stockholders who do not wish to withdraw their previously submitted redemption requests (either in connection with the Special Meeting or the upcoming Annual Meeting) need not take any further action.
  • This communication does not contain all the information that should be considered concerning the Annual Meeting.

Manuka Announces Review of Strategic Alternatives

Retrieved on: 
Thursday, November 16, 2023
Sale, Disclosure, Special-purpose acquisition company, OTCQB, Annual report, Risk, OTC Markets Group, Capital market, OTC, Security (finance), Manuka

Petach Tikva, Israel, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Manuka, Inc. ("Manuka" or the "Company") (OTCPINK:MNKA), a beauty company that develops and distributes premium-quality skincare products that are based on Manuka honey and bee venom, announced today that following a review of its business, resources and capabilities, it is exploring strategic alternatives focused on maximizing stockholder value.

Key Points: 
  • Petach Tikva, Israel, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Manuka, Inc. ("Manuka" or the "Company") (OTCPINK:MNKA), a beauty company that develops and distributes premium-quality skincare products that are based on Manuka honey and bee venom, announced today that following a review of its business, resources and capabilities, it is exploring strategic alternatives focused on maximizing stockholder value.
  • As part of this process, the Company has engaged ACP Capital Markets LLC (“ACP”) as an advisor to the Company in this process.
  • Strategic alternatives being evaluated include the sale of all or part of the Company, merger or reverse merger.
  • For example, Manuka is using forward-looking statement in this press release when it discusses strategic alternatives being evaluated or when it discusses the potential listing of Manuka’s shares on the OTCQB.